Lespcl

Actos Bladder Cancer : Not resting on their laurels, the clinical research community has moved forward and is now testing a new combination that adds paclitaxel, another active drug mentioned above, to the gemcitabine- cisplatin regimen. A three-drug combination (gemcitabine-cisplatin- paclitaxel) has been compared to the two-drug standard, to see whether this produces better cancer shrinkage and improved survival. In June 2007, the first report of this trial was made public. It indicated that the three-drug combination offered no significant benefit compared to gemcitabine-cisplatin and was associated with more side effects.

Another new agent, pemetrexed, also targets the division and reproduction of cancer cells, and has a relatively gentle profile with regard to side effects. It is being tested in patients who have already been treated with gemcitabine and cisplatin to see whether it will cause tumor shrinkage. Early reports are promising, but its true use­fulness is not yet known, and it has not yet been assessed by the Food and Drug Administra tion, which must give formal approval for its use in the treatment of bladder cancer.

In addition to the use of chemotherapy, another class of anti-can- cer agents, the so-called growth inhibitors or targeted agents, is being tested in patients with advanced bladder cancer. It is known that pro­teins located on the surface of cancer cells can control the rate of DNA production and division and stimulate cancer-cell growth. An example is the epidermal growth factor receptor (EGFR), which sits on the surface of some bladder-cancer cells and helps to control the rate at which they grow and divide. Inhibitors of the function of EGFR (and of the genes that control its production) have been developed and are known to slow or stop the growth of some cancer cells.

More information on Actos Bladder Cancer

You may be alarmed if your doctor suggests the possibility of par­ticipating in a clinical trial Does it mean that you have no hope? What should you do? How should you respond? It’s important not to dismiss the idea out of hand. The words experimental, research, and human volunteer can be upsetting, particularly at a time when you are dealing with the emotional issues surrounding a diagnosis of advanced cancer. But treatments in clinical trials can often be highly beneficial to those who volunteer. You and your loved ones should talk with your medical team members about the kind of clinical trial they are recommending and why it may benefit you. In fact, several studies have shown that patients participating in clinical trials have better outcomes than those found in the community at large. However, this also may be due to the types of patients who agree to participate in trials.

Does referral to a clinical trial mean that there is no hope of your surviving this illness? Not at all! There is always hope of survival, and any doctor can tell you about people who have responded positively to treatment and not only survived, but thrived. Being in a clinical trial doesn’t mean that you won’t continue to receive medical treatment; you wall, and since it’s a voluntary process, you have the right to stop participating in the trial at any time.

As with any aspect of your treatment plan, you make the decision about whether to proceed. Don’t feel pressured to participate in a trial if it doesn’t feel right for you, but do give it objective thought and consideration. How do you begin thinking through the decision on whether to participate in a trial?

Information from other sources on Actos Bladder Cancer

Probably the first question that comes to your mind is whether clinical trials are safe. Scientists and medical investigators work hard to ensure that they are as safe as possible. The medical community and the U.S. Department of Health and Human Sendees have put rules in place ensuring that every clinical trial is highly regulated and reviewed by health-care professionals, who determine that the trial is designed and conducted in compliance with federal regulations gov­erning research on human volunteers. Everything about the trial, from the doctors involved to the people who volunteer and the treat­ment being tested, is subject to strict review and monitoring. However, it is important to understand that some clinical trials do carry increased risks.

As with any treatment, you’ll want to ask about possible risks, ben­efits, side effects, how the treatment works, and what results doctors expect from the study.You’ll want to know who is conducting the clin­ical trial and what kind of oversight is in place. Also ask what is expected of you. Where will you go for the treatments? How often will you go? Are there more tests or office visits than you might have with standard treatment? Who administers the treatments and how are the results measured? Do you have to report regularly to those running the trial? Who pays for it all? Will there be extra costs to you as a result of your participation? Will the team conducting the trial (or the doctors involved) stand to benefit personally from the results of the trial or its conduct?

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Actos Bladder Cancer : The word “invasive”refers to whether cells from your bladder cancer have “invaded” the muscle wall of the bladder, and if so, how far into the layers of muscle tissue it has penetrated.This can usually be deter­mined from biopsy results, or occasionally when an operation has been performed to remove the bladder and some of the surrounding tissues. In some cases, organs near the bladder (such as the vagina in women, or the prostate in men) may have been invaded as well.

Invasive cancer extends further into the body than superficial TCC does and is therefore a more serious stage of the disease. It requires more complicated treatment, such as surgical removal of the bladder. This may, in turn, change how you manage basic physical functions in your everyday life, such as your bathroom habits and even your sex life. Also of importance is the significant rate of recurrence connected with invasive cancer. Often other organs, such as the lymph nodes, lung or liver, are involved.

Despite such a gloomy introduction to this chapter, there is every reason for you to be hopeful if youVe been diagnosed with invasive cancer. Current treatment, which includes surgery (cystectomy), chemotherapy, radiation therapy, or two of these approaches com­bined, offers you an excellent chance for long-term survival and, in many cases, for a cure. This applies particularly to those invasive tumors that have not penetrated outside the bladder, the so-called ” organ- confined” tumors.

More information on Actos Bladder Cancer

There is no question that the after effects of surgical removal of the bladder (cystectomy) can be unsettling to think about. You won’t have a bladder or maybe even a urethra any longer. How will you be able to pass urine? Will you have to have some type of urine-collect­ing bag? Will there be an odor? Will it show when you wear certain clothing? We’ll talk about all those things in more detail, but in brief, your team will need to surgically create an artificial urine-collection system for you. This is known as a urinary diversion system. In years past, the only option was a urine-collection bag worn outside the body which many people found to be unpleasant or even embarrassing.

The good news is that now, in many cases, an artificial bladder (sometimes called a neobladder) can be fashioned from a piece taken from the intestine (bowel), enabling you to void urine in a normal or near-normal fashion. You’ll have to learn to use a different set of mus­cles when urinating, and there may be some leakage now and then, particularly at night. Leakage can be controlled by wearing under­wear designed with a disposable pad or, for men, a sort of condom. Overall, it’s a more attractive option that makes it easier to face a complicated and often scary surgery such as cystectomy. And with modern techniques, most patients no longer have to contend with urinary leakage, except on rare occasions.

Even if you are disappointed because the creation of an internal urinary diversion system is not possible in your situation, keep in mind that there is also no question that cystectomy is a powerful weapon against invasive bladder cancer that can increase your odds of living a long, cancer-free life. Cystectomy is the most common treatment option for invasive blad­der cancer. In most cases, your medical team will recommend a com­plete (or radical) cystectomy. This means that your bladder, the lymph nodes tucked around your bladder in the abdomen, the prostate in men, and the uterus, ovaries, and part of the vaginal wall in women will be surgically removed. Depending on where the cancer is locat­ed, the urethra may also be removed.

Information from other sources on Actos Bladder Cancer

It’s easy to confuse some of the terms your doctors use, such as “cystoscopy”(a diagnostic pro- cedure that introduces a tube into the bladder so that the doctor can look at the inner surface and take a biopsy) and “cystectomy” (the surgical removal of the bladder). Don’t hesitate to ask your doctors for clarification. Cystectomy seems like a drastic surgery, doesn’t it? Why remove so many body parts? Why not just take the tumor and some surrounding tissue?

Depending on where your tumor is located, the cancer-causing substances responsible for the tumors in your bladder were also fil­tered through the kidney, ureters, and urethra, and there is a possibil­ity that tumors may be forming in those organs, too. In particular, the tissues lining the bladder, ureters, and urethra (known as the urothe­lial tissues) may be at risk from the after effects of cancer-causing substances, such as agents in cigarette smoke or industrial dyes. Also, because your cancer may have penetrated the muscle wall, it’s possi­ble that organs surrounding the bladder, such as the prostate, uterus, or vagina, may also be at risk from further growth of the cancer cells.

So in the case of bladder cancer, which often recurs or spreads to other organs, you’ll have a much better chance of a cure once organs and tissue have been removed in areas where the disease is likely to spread or where it may already have infiltrated. And a cure is what you and your doctors most definitely want to strive for. Sometimes, if the cancer is very localized and surrounded by plenty of healthy, noncancerous tissue, a partial cystectomy might be recommended, whereby only a portion of the bladder is removed and some or all of the surrounding organs may be saved.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : When an individual has gross hematuria or persistent microscopic hematuria, a complete assessment of the urinary tract is required. Although cystoscopy is the test of choice for examination of the bladder, imaging studies are required to make sure there is no disease in the upper tracts (kidneys and ureters). Bleeding can be caused from many different disorders including transitional cell carcinoma of the upper tracts, kidney or ureteral stones, or renal cell carcinoma (cancer of the parenchyma or fleshy part of the kidneys). Your urologist has a number of options to choose from. There are advantages and disadvantages of each.

Intravenous pyelogram (IVP) is accomplished by injecting a contrast agent into your vein and then obtaining X ray images. The contrast is excreted by your kidneys, subsequently filling the lumen of the kidneys, ureters and the bladder. The contrast allows one to see subtle filling defects within chambers of the urinary tract, possibly representing tumor, stone or blood clot. Tumors of the fleshy part of the kidneys can also be seen. The study also allows for an assessment of renal function. It is a sensitive test for renal obstruction, which can occur because of cancer. Disadvantages of the study include the possibility of an IV contrast agent allergy, which occasionally may be serious.

You will be asked whether you have a sea food allergy, a known allergy to iodine or to IV contrast. If this is the case, you may need to be premedicated prior to the exam to avoid a reaction. Although the study is quite useful at visualizing the upper tracts, it is not very good at picking up subtle tumors on the bladder surface. If your kidneys do not function well (you have renal insufficiency), the contrast may cause harm to your kidneys and the imaging will not be as good. For pregnant women, any X ray exam could be potentially damaging to the fetus and therefore, will not be performed.

More information on Actos Bladder Cancer

Ultrasonography can check for a kidney tumor, stone, or obstruction. Bladders filled with urine can be scanned. There is no contrast or X rays involved, and therefore the study can be accomplished in those with renal disease, contrast allergies or for women who are pregnant. Although larger tumors of the bladder are often visible, it is not a good study to rule out urothelial cancer (transitional cell cancer of the urinary tract lining) since smaller tumors or flat tumors in the lining are not visible. Also, other conditions such as enlarged folds in the bladder or enlarged prostates can be confused with bladder tumors. Ultrasound exams are generally fast, painless, and relatively inexpensive. An ultrasound combined with cystoscopy plus cytology (to rule out cancer cells) is a reasonable assessment for those with a low likelihood of having upper tract disease.

CT Scan or CAT (computerized axial tomography) provides a computerized cross sectional visualization of the abdomen and pelvis. X ray images are synthesized into exquisitely detailed images. The CT scan can be done with or without IV contrast, and therefore has the same limitations as IVP in those with allergies to contrast or renal insufficiency. These studies are excellent for finding renal cell cancers and stones within the kidneys and ureter, but not very good at delineating cancers of the lining. CT scan is often an important part of staging bladder cancer, determining whether the cancer has spread.

Magnetic Resonance Imaging (MRI) is a technology which uses strong magnets to provide detailed images of your internal organs. Like ultrasound, this study has no known harmful effects on the body. It does not require contrast injection like CT scan and can be done safely in patients with renal insufficiency. It is not generally used for initial screening. Many individuals find the test uncomfortable due to a loud noise heard throughout the test, in addition to the close quarters the machine requires, leading to feelings of claustrophobia. A mild sedative may be required if the test is necessary and the individual experiences these uncomfortable feelings.

Information from other sources on Actos Bladder Cancer

Initial treatment may eradicate an individual’s bladder cancer, however, for many, recurrent tumors may develop. Up to 70% of individuals will have recurrent bladder cancer after initial therapy. In approximately one third of patients, not only will tumors recur, but they will become more serious over time, developing a higher grade or stage. This chapter will review the importance of staging bladder cancer, the single most important predictor of future problems. In addition, we will review other important indicators that impact the prognosis.

After the diagnosis of cancer is made, it is critical to establish the stage of the cancer. Cancer stage quantifies the extent of cancer in the individual. The number of tumors, their size, whether or not they have grown into the wall of the organ or spread beyond, all fit into the various stages of a particular cancer. Most cancers can be found at an early, nonlethal stage. As they grow and worsen, they can invade the wall of the organ they lodge in, spread locally through the organ into surrounding tissue, or spread throughout the body via the lymphatic or blood system.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : Apart from giving up smoking, follow-up is the best preventive meas­ure there is for bladder cancer. For the first two years after treatment, you’ll have a cystoscopy, usually every three to four months. If no further tumors are found during that time, follow-up every six months for an additional two years is usually adequate, with annual cystoscopies after that. Since bladder cancer can recur in later years, most doctors in the United States prefer to do annual follow-up cystoscopies for the rest of the patient’s life. Some physicians will reduce the number of cystoscopies by alternating them with the urine cytology test, whereby urine is collected and examined for the presence of can­cer cells under a microscope.

There is some discussion in the medical community about whether routine screening for blood in the urine might lead to earlier diagno­sis for those who are at high risk of recurrence. At present, these screening tests are not accurate enough to be completely reliable, but as technology advances, so will the sophistication of such tests, enabling people like you to monitor their disease more frequently and with far more comfort.

Many people claim that diet, antioxidants, and various other healthful lifestyle approaches are helpful in the battle against cancer or in retarding the progress of cancer. Frankly, the data are pretty thin, but we believe that it is a good idea to take regular exercise and con­sume a “heart-healthy” diet low in cholesterol and fats and high in whole grains, legumes, fruits, and vegetables. This doesn’t apply only to the battle against cancer; it just makes good sense when you’re try­ing to live a long and healthy life. In light of some of the published medical data, it is probably also a good idea to keep your fluid con­sumption up, as there is some evidence that bladder cancers occur less frequently in people who have high fluid intake.

More information on Actos Bladder Cancer

You may have a catheter in your urethra to help prevent bleeding or blockages. In that case, you may have to stay in the hospital for a day or two following surgery. (When possible, resection is performed on an outpatient basis.) If you are released the same day, your doctor should review possible after effects such as frequent urination, urine blockage, bladder infection, or blood in the urine and let you know what you should do if you experience any of them. Make sure you ask whether there are any restrictions on activity or exercise. Your doctor also should explain any risks, such as blood clots or perforation of the bladder.

There are numerous commercial brands of preparations used for immunotherapy and numerous treatment plans for administering them. You’ll want to know the details of the immunotherapy plan for you as well as what specific side effects (such as burning or chills and fatigue) are associated with the immunotherapy preparation you receive. Your doctor should tell you which members of your medical team to speak with if you experience ongoing problems or have con­cerns. Your doctor should tell you when to be concerned about side effects and what to do (e.g., make an office appointment or go to the emergency room).

Make sure that your doctor schedules a follow-up cystoscopy in about three months and discusses whether any of the newer screening tests for bladder-cancer “markers” might be appropriate for you. If you are still smoking, your doctor should encourage you to enroll in a program to help you quit. Make sure that your doctor reviews the symptoms that might signal a recurrence and discusses what you should do if you experience any of them.

Information from other sources on Actos Bladder Cancer

Cancer transforms everyone it touches; many cancer survivors describe their experience as a deep and motivating change. They find that what was “normal” during their pre-cancer lives no longer applies. Some say that life seems sweeter, that they are embracing life with a gusto and appreciation they didn’t have before. Others feel the shadow of worry that their cancer might return, and some are gripped by guilt that they survived cancer while others were not so lucky.

Sometimes cancer survivors are quick to view their personal tri­umph over their disease as a benchmark for handling anything that might come their way in life, including a recurrence. Others who nei­ther surge with confidence nor shake their fists at fate gradually return to a happier outlook, their faith in their health increasing along with hopes for the future. Being diagnosed with cancer often gives people the feeling that they have no control. Survivorship is all about learning to take control over how you live the rest of your life.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : Recently, a number of clinical studies have demonstrated that in select individuals with muscle invasive bladder cancer, utilization of three modes of therapy can be effective in controlling invasive bladder cancer. These bladder preservation protocols have found those individuals that do best have smaller, invasive bladder cancers that can be completely resected. Resection is followed by radiation, which is then followed by chemotherapy. Those that fail the initial treatment go on to cystectomy. Long term bladder preservation in some studies is achieved in approximately 40%.

It should be noted however, this high rate of success may be contingent on choosing patients with less serious disease than the average patient undergoing cystectomy. Platinum based chemotherapy appears to offer the best results; however, the best combination regimen of chemotherapy is still being studied. Individuals with large, invasive canccrs and those with associated CIS or hydronephrosis secondary to cancer are not considered good candidates for bladder preserving therapy. Side effects of therapy are predominately the effects of chemotherapy, and include nausea, vomiting, diarrhea, fatigue, and sepsis secondary to lowered immunity.

After removal of the bladder, an approximately 6 inch piece of small intestine from the ileum (the final section of small intestine) is surgically separated from the rest of the small intestine. This section of bowel is used to create an ileal loop diversion. The ileum is the best section of small bowel to use since it has the lowest rate of electrolyte (body salts) disturbances afterwards. The ileum from which this section is removed is reconnected via suturing or staples.

More information on Actos Bladder Cancer

The future ileal loop is flushed clean and the base of the loop is sewn shut. The ends of both ureters are then carefully sewn to a small opening made close to the base of the ileal loop. The opposite end of the ileal loop is brought out through the skin and secured. The end of the loop is everted and tied down to the skin to create a raised stoma. Usually, small plastic tubes called stents are placed through the ileal loop, up the ureters, with their ends curling in the kidneys. These stents are temporary, generally left in for several weeks. Stents serve the purpose of decreasing urinary leakage at the anastomosis (the connection of the ureter to the ileal loop) and serve to allow the anastomosis to heal in an open fashion, thereby reducing the incidence of scarring. The ileal loop is the simplest and quickest form of urinary diversion. Post-operative complications are infrequent. Given these advantages, it remains the most common form of urinary diversion.

Although one can bring a ureter directly to the skin surface, it is generally not a good form of diversion. The ureters are flimsy, making them prone to obstruction if they are brought out directly. It may also be difficult to bring both ureters to the same place, thus necessitating two drainage bags. The ileal loop serves as a conduit and not a reservoir. The ureters are attached to it at its base. The ileal loop then traverses the skin and underlying tissues to allow unimpeded flow of urine. Urine flows continually through the loop and is collected in a bag attached over the exit of the loop, called the stoma.

Flernia: During the formation of an ileal loop or continent diversion, the ileal loop is brought out through a peritoneal opening, then through fascia (a thick supporting layer) out through the skin. If a gap exists or develops through the fascia, a parastomal hernia can develop. A hernia represents an abnormal pocket of peritoneum and possibly includes bowel. In addition, a hernia may develop through the surgical incision, which is called an incisional hernia. There is also a higher incidence of inguinal hernia (groin hernia) developing after surgery. Malnutrition, obesity, and lung diseases resulting in labored breathing all increase the risk for a hernia occurring. Many hernias require surgical correction.

Information from other sources on Actos Bladder Cancer

Kidney deterioration: If an individual faces recurrent urinary infections involving the kidneys, or has kidney stones, the kidneys may gradually lose function. Fortunately, this complication is rare. Your urologist will aggressively treat uninary infections, stones or deal with other complications which can impair kidney function.

Kidney stones: There is a small but real increased rate of kidney stones after an ileal loop diversion. Kidney stones are most often treated with ESWL (extracoporeal shock wave lithotripsy, a machine that can focus shock waves through the body to break up the stones).

Skin irritation: The skin surrounding the stoma and sometimes the skin beneath the collection bag may become reddened and irritated. By working with your enterostomy nurse, you will learn how to make your ostomy appliance more adherent. Sometimes, application of an ointment to the skin to protect it from the irritating effect of urine is required.

Stomal stenosis: Sometimes the stoma may be too tight, causing urine to pool in the ileal loop, leading to a urinary infection. This can be determined via a loopogram (an X ray study of the loop filled with contrast). Surgical correction of the loop is often required to resolve this problem.

Urinary infection: The ileal loop often can become colonized with bacteria. Colonization does not result in inflammation or any symptoms. However, bacteria may invade the wall of the ileal loop or travel up to the kidneys, resulting in infection. Symptoms may occur, including pain in the loop, kidney pain, blood in the urine, or increased sediment. A fever may occur, especially with kidney infection. To test for infection, urine is collected for culture directly from the loop. Appropriate antibiotics are then used to resolve the infection.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : Hernia: After surgery, there is an increased risk of developing an incisional hernia (a hernia through the original incision) or an inguinal hernia (a hernia in the groin). A hernia represents a weakening of the thick outer layer of tissue which holds the abdominal contents in place. With a hernia, there is an abnormal protrusion of peritoneal sac and possibly bowel. Herniation of bowel may lead to a lack of blood flow to the herniated intestine which can be serious if left untreated. Surgical correction of the hernia is usually recommended to avoid this possibility and to eliminate discomfort.

Prolonged ileus: For some individuals return of bowel function may be delayed by several days or longer. Your urologist will be following you carefully to make sure a bowel obstruction or bowel leak is not present. Ileus may require leaving the nasogastric tube in to suction off excessive fluid. In addition, hyperalimentation (complete nutrition delivered intravenously) may be initiated if the ileus is prolonged.

Urine leak: The ureters are sewn to the ileal loop in a watertight fashion. In addition, small tubes, called stents, are placed through the ileal loop, through the anastomosis of the ureter to the loop, up the ureter into each kidney. These tubes are placed to allow the ureteral-ileal anastomosis to heal and to prevent leakage. They are generally removed weeks after surgery. Besides these stents, a drain or drains are placed to siphon off any urine which may still leak from the anastomosis. Prolonged urine leakage into the abdomen will generally result in ileus and possibly secondary infection. Persistent urine leak may result from the lack of good blood supply to the ends of the ureters. Leakage is also increased in those who have had pelvic radiation in the past for other malignancies. Prolonged leakage may require repeat surgery.

More information on Actos Bladder Cancer

Wound infection: The rate of wound infection is low. Rates are increased in diabetics, obese individuals, prolonged surgery, and in those individuals whose body temperature drops excessively during surgery. Excellent surgical technique and the use of antibiotics can lower the rate. Wound infections generally will require opening the area to allow drainage. Wound infection can result in weakening of the abdominal closure, which can cause a hernia or more rarely an evisceration (a disruption of the abdominal closure), requiring immediate surgical closure.

Cardiovascular complications: Major surgery can result in significant physical stress to the body and its physiology. Cardiac arrhythmias (abnormal heart beats) may occur and warrant medical therapy to correct. If serious, a cardiologist may be consulted. Life threatening arrhythmias may require cardioversion to correct or even the possibility of a pacemaker. A heart attack (a vascular blockage to the heart) or a cerebrovascular accident also referred to as a stroke, are fortunately rare, but sometimes devastating complications which can prove to be fatal. It is essential an individual facing major surgery with cardiac or vascular disease be properly screened prior to surgery to rule out and correct any serious underlying abnormalities. One should not face surgery with an unstable major underlying condition without correction or improvement when this can be reasonably achieved.

Pulmonary problems: After surgery, it is essential to do deep breathing exercises usually with a device called a spirometer. Bed rest, pain from surgery, and the sedative effects of pain medication can all lead to inadequate aeration of the lungs, which can lead to atelectasis (a collapsed area of the lung). Left untreated, atelectasis can lead to infection (pneumonitis or pneumonia), a potentially serious complication. For those with preceding lung disease, a respiratory therapist will likely be requested to work with the patient to clear lung secretions and increase aeration to prevent infection.

Information from other sources on Actos Bladder Cancer

Another potential serious pulmonary problem is called pulmonary embolus. A pulmonary embolus causes damage to the lung by a blood clot which forms in another area of the body, travels through the veins of the body and ends in the lungs. Blood clots can form in the pelvic veins as a result of surgery. They can also form in the lower extremities because of prolonged bed rest and immobility after surgery. Compression stockings used during and after surgery until mobility resumes help to prevent clots in the legs. Getting the individual out of bed and ambulating as soon as possible after surgery are important to prevent clots from forming. In addition, subcutaneous heparin (a medication that stops clotting) can be given during the post-operative period to lessen the possibility of pulmonary embolus without a substantial increase in post-operative bleeding. The symptoms of a pulmonary embolus are shortness of breath and pain in the chest with breathing.

Clinical signs include a rapid heart beat and poor oxygenation of the blood. Diagnosis is confirmed with a ventilation-perfusion scan. This study will demonstrate a lack of blood flow in various parts of the lung which have good air flow (a finding consistent with a vascular blockage by a clot). In many institutions, a CT angiogram of the lungs has become the preferred study because of the speed of the study and its enhanced accuracy. An individual must not be allergic to IV contrast, nor have significant renal insufficiency if this test is to be ordered. Pulmonary emboli are usually treated with supportive measures such as supplemental oxygen and anti-coagulation of the blood to prevent further clots from forming and migrating. If a large clot has formed and continues to embolize to the lung, a small filter device may be placed in the main vein of the abdomen (the inferior vena cava) to prevent further clots from traveling to the lungs.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer :

More information on Actos Bladder Cancer

If the results of your tests-—-either scans or biopsies-—- show that cancer has spread to other tissue or organs, your doctor will want to confirm that. Clarification of the stage of your cancer comes through looking at the cancer cells from those organs under the microscope. Tissue samples may be taken at the time of your biopsy, or sometimes a needle biopsy is done, bypassing the need for additional surgery.

Pathologists stage bladder-cancer tissue by using a standardized system known as TNM, which stands for tumor- nodes-metastases. A typical TNM might be “T2aNlM0” (T-two-a-N-one-M-zero). Looks like mumbo jumbo, doesn’t it? Try thinking of it as medical shorthand, with each letter and numeral having a defined value that gives doctors and pathologists a specific, consistent way to describe how deeply a cancer has invaded the body’s tissue and organs.

Information from other sources on Actos Bladder Cancer

The TNM system uses the letters T, N, and M followed by numerals to describe the stage of invasiveness of your cancer.

The letter T followed by a numeral from one to four (1 to 4) describes the depth of invasiveness of your tumor. The lower the number, the less invasive the cancer.

The T scale has additional, more detailed levels as well. These levels add the lowercase letters a and b to the T score to delineate more precisely how far into the bladder your cancer has spread and whether it has moved into other areas of your body. It fine-tunes the pathology information to help your doctor make treatment recommendations.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Lawyers12/20/2011: There are multiple factors which must be considered. Generally younger patients, those in better overall health, and those with excellent preoperative erections can expect a more rapid return of erectile activity if the nerve sparing approach is successful. Even with meticulous nerve sparing, some nerve injury, either temporary or permanent may occur. The extent of the injury will determine how quickly erections may return. Erections may start returning in as little as two to three months, or may gradually return over a period of a year, or may not return at all.

For more information on Actos Lawyer follow us on our RSS Feeds.

Our use of the Terms Actos Lawsuit, Actos Bladder Cancer is not intended to imply or insinuate that there is any relationship or connection between Best Legal Source and the maker of Actos. Actos is a trademark of its manufacturer, Takeda Pharmaceutical Company Limited. Best Legal Source is not the maker of Actos nor do we have any connection with Takeda Pharmaceutical Company Limited.

http://www.seedol.com